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Effects of antihypertensive drugs on glomerular morphology
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Effects of antihypertensive drugs on glomerular morphology. We
quantitated the glomerular size and the degree of sclerosis simulta-
neously in individual glomeruli with the use of three-dimensional
histological analysis on serial sections obtained from remnant kidneys
with highly heterogeneous glomerular lesions after subtotal nephrec-
tomy (sNPX). Four to six weeks after sNPX (Group I, N = 7), 90% of
glomeruli had mild sclerosis (sclerosis index, SI; < 1.5 on a 0 to 4 scale)
with a strong positive correlation between the maximum planar area of
glomerulus (PAmax) versus SI. Twelve weeks after sNPX (Group II, N
= 6) more than 50% of glomeruli had advanced sclerosis (average
Sl:l.88), and a significant positive correlation was again found between
PAmax and SI in glomeruli with mild to modest sclerosis (SI < 1.5),
whereas these two variables were correlated inversely in glomeruli with
advanced sclerosis. Administration of enalapril (50 mg/liter drinking
water) or hydralazine (200 mg/liter) + reserpine (10 mg/liter) + hydro-
chlorothiazide (50 mg/liter) for 12 weeks (Group Ill, N = 12) markedly
attenuated the sclerosis to comparable degrees (average SI: 0.15 vs.
0.22). The former antihypertensive therapy decreased glomerular cap-
illary hydraulic pressure (P0) to normal range, whereas the latter triple
drug therapy was largely without effect on P0. Of note, the positive
correlation between SI and PAmax remained unaffected by these
anti-hypertensive drugs. SI of the glomeruli from both treated groups
was expressed as a first-order function of PAmax. The correlation
coefficient is identical to that found in non-treated Group II remnant
glomeruli, so that the degree of sclerosis is mathematically uniquely
correlated with the glomerular size, regardless of drug treatment. Thus,
within a given remnant kidney, the magnitude of glomerular hypertro-
phy has a direct correlation with the degree of sclerosis, while the
altered glomerular hemodynamic pattern has little modulatory role in
determining the magnitude of this hypertrophy. Enalapril and triple
drug therapy, at equi-depressor doses in regard to systemic blood
pressure, had identical potency in sparing glomerular structure. The
primary determinant for this antisclerotic potency appears to be related
to the drugs' potency to inhibit glomerular growth rather than an effect
on the abnormal hemodynamics which develop in the glomerulus.
In searching for a clue to our understanding of the cause for
the often incessant deterioration of the glomerular architecture
in chronic renal diseases, efforts have been made in animal
studies to identify early functional or histological changes
which precede the onset of this destructive process in the
glomerulus. The relevance of several early changes thus found
has been further evaluated in recent studies by examining the
persistent close association between these changes and the
subsequent glomerular histological abnormalities during a van-
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ety of dietary manipulations or drug administrations [1—131.
Elevation in glomerular pressure/flows and hypertrophy of the
glomerulus are two such early changes documented thus far as
being closely associated with sclerosis [1—3, 10—121. Careful
assessment and follow-up of these and various other indicated
functional or structural parameters over time combined with
subsequent quantitation of histological abnormalities within the
same glomeruli among such markedly heterogenous nephrons
allow rigorous evaluation of the causal role of those early
parameters. This approach is devoid of the shortcomings inher-
ent to the conventional animal-to-animal comparison performed
under dietary manipulations or drug administrations, such as 1)
a potentially wide animal-to-animal variability in the glomerular
susceptibility to injuries, 2) a potential multiplicity of the
biological effects that drugs and dietary manipulations have on
unknown, unassessed intermediary mechanisms, and 3) a wide
glomerular heterogeneity which hinders the detection of subtle
differences in the effectiveness of different manipulations. A
new experimental approach based on the marked functional and
structural glomerulus-to-glomerulus heterogeneity common to
chronic renal diseases has been developed recently [14, 15].
This methodology allows us to serially analyze single glomeru-
lar function by micropuncture over an extended period of time
and, subsequently, to quantitate the histological abnormalities
of the same glomerulus for its entire corpuscle. By assessing the
early and late parameters within the same glomeruli, it has,
therefore, become possible to test the hypothesized causal
linkage discussed above. Our recent studies employing this
serial micropuncture technique in the rat remnant kidney model
[14] revealed that the magnitude of the hemodynamic abnor-
malities which develop in the remnant glomeruli had no appre-
ciable relationship to the degree of sclerosis subsequently
appearing in the same glomerulus. Given the highly reproduc-
ible nature of the light microscopic and micropuncture tech-
niques, the observed lack of correlation was taken to indicate
the need for exploring other or additional mechanism(s) caus-
ally active in the development of glomerular sclerosis.
In the present study, therefore, the potential causal linking of
the glomerular hypertrophic process to the sclerosis was tested
by examining the correlation between the degree of sclerosis
and corpuscular size in individual glomeruli of the remnant
kidney. If the process involved in the glomerular hypertrophy
has a direct and profound causal impact on the development of
glomerular sclerosis, we would be able to detect a strong
positive correlation between the glomerular size and the degree
of sclerosis among the highly heterogenous remnant glomeruli.
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Group II
Fig. 1. Schematic presentation of the experimental protocols for Groups!, 1! and III.
In addition, we assessed periodically the hemodynamic param-
eters by the serial micropuncture technique in the same glomer-
uli analyzed histologically in order to examine the potential
causal linkage between enhanced glomerular hemodynamic
pattern and hypertrophy. This protocol was geared to test the
so-called "work load hypothesis" for renal hypertrophy at the
glomerular level.
Studies in the past showed that some antihypertensive drugs
possess a protective effect against the development of sclerosis
in remnant glomeruli in association with marked diminution of
both hypertrophy and enhanced glomerular hemodynamic pat-
tern [2]. In the present study, therefore, two antihypertensive
drugs used in the past [2, 3, 13] were tested for their effects on
glomerular size, hemodynamics and sclerosis at the individual
glomerular level in the remnant kidney. If the glomerular
hypertrophic process, and not glomerular hemodynamics, is of
primary importance in determining the degree of glomerular
sclerosis, a consistent correlation between glomerular size and
sclerosis should be present regardless of the quality and quan-
tity of the antihypertensive medication given or of the glomer-
ular hemodynamic patterns which once prevailed in those
glomeruli.
Methods
General
Experiments were performed in 25 adult male Munich-Wistar
rats weighing 200 to 240 grams. All rats underwent subtotal
nephrectomy, that is, right nephrectomy and ligation of two or
three main branches of the left renal artery by silk ligature to
leave approximately 1/6 to 1/8 total kidney tissue mass. The
animals were allowed free access to regular rat chow and tap
water before and after subtotal nephrectomy except for the —15
hours immediately prior to each micropuncture measurement,
when they were given water only. Systolic arterial pressure and
BUN were measured periodically; the former by the tail cuff
method [16] in awake animals, as well as in the anesthetized
immediately prior to, and following, micropuncture studies.
During the procedures of subtotal nephrectomy or serial micro-
puncture assessments specified below, animals were anesthe-
tized with sodium pentobarbital (Nembutal, Abbott Laborato-
ries, North Chicago, Illinois, USA; 25 to 30 mg/kg body wt, i.p.)
with the exception of the final micropuncture study, in which
Inactin (BYK, Konstanz, FRG; 100 mg/kg body wt, i.p.) was
used.
Experimental groups
Group 1:4 to 6 week observation after subtotal nephrectomy(N = 7 rats). After mapping of surface glomeruli (described
below), the first micropuncture measurements and subtotal
nephrectomy were performed (Fig. I). Micropuncture measure-
ments of single nephron glomerular filtration rate (SNGFR),
mean glomerular capillary hydraulic pressure (PGC) and Bow-
man's space hydraulic pressure (PBS) were repeated two, four
and six weeks later on the same nephrons. At six weeks,
micropuncture assessments were followed by marking of gb-
meruli (specified below), and animals were sacrificed for histo-
logical studies. Glomerular sclerosis index and maximum planar
area of the glomerulus (PAmax, specified below) were obtained
from the glomeruli subjected to the above micropuncture as-
sessments.
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Group II: 12 week observation after subtotal nephrectomy
(control for antihypertensive treatment) (n = 6 rats). Twelve
weeks after subtotal nephrectomy, glomerular sclerosis index
and PAmax were obtained at the single glomerular level. At
least 20 glomeruli were examined for each kidney for the
assessment of the relationship between glomerular sclerosis
index and PAmax. The whole kidney sclerosis index was also
obtained from each kidney.
Group III: 12 week observation after subtotal nephrectomy
(anti-hypertensive treatment) (n = 12 rats). Three days after
subtotal nephrectomy, animals were placed on one of the
following antihypertensive treatments:
(1) Enalapril: enalapril maleate (Merck Sharp & Dohme
Research Laboratories, Rahway, New Jersey, USA), 50 mg/
liter in drinking water.
(2) Triple drugs: hydralazine (Sigma Chemical Company, St.
Louis, Missouri, USA; 200 mg/liter in drinking water) + reser-
pine (Sigma Chemical Co.; 10 mg/liter in drinking water) +
hydrochlorothiazide (Sigma Chemical Co.; 50 mg/liter in drink-
ing water). Since reserpine and hydrochlorothiazide are not
dissolved in water, these drugs were dissolved in ethyl alcohol
first and then mixed with drinking water. The triple drugs were
protected from ultraviolet light by wrapping the water bottles in
aluminum foil.
Glomerular sclerosis index and PAmax at the single nephron
level and the whole kidney glomerular sclerosis index were
assessed as in Group II. In addition, serial micropuncture was
performed to examine the time course of P on the same
glomeruli at 3, 7 and 12 weeks.
Serial micropuncture methods
Mapping of surface glomeruli. To perform serial micropunc-
ture assessment on the same nephrons, geographical locations
of surface glomeruli and the earliest segments of proximal
convolutions immediately downstream were recorded in Group
I and HI rats in the following manner [14]. Pairs of surface
glomeruli and the earliest segment of proximal tubules originat-
ing from these glomeruli were identified by injecting, (with a
pipette of —4 m outer tip diameter) with modest pressure, a
small quantity of 0.1% lissamine green into proximal convolu-
tions in the vicinity of surface glomeruli. To record the location
of the surface glomerulus, photographs were taken on color film
(Polaroid Polacolor ER Type 559, Polaroid Corporation, Cam-
bridge, Massachusetts, USA) through a stereomicroscope (Ste-
reoscopic Microscope SMZ- 10, Nippon Kogaku K. K., Tokyo,
Japan) adapted with a photomicrographic system (Microfiex
UFX-2, Nippon Kogaku K.K.) attached to a Polaroid camera
(Polaroid 4 x 5 Land Pack Film Holder #550). In addition, the
contour of the tubules adjacent to each surface glomerulus was
outlined in a notebook to assist in the identification of surface
glomeruli during the subsequent micropuncture measurements.
Micropuncture measurements. Precisely timed (1 to 2 mm)
samples of fluid were collected from surface earliest segment of
proximal tubules previously identified for determination of
earliest proximal fluid flow rate, hence single nephron glomer-
ular filtration rate (SNGFR). As described in detail elsewhere
[14], the earliest proximal fluid flow rate determined in this
manner was shown to represent SNGFR faithfully. For the
purpose of this timed fluid collection, mineral oil stained with
Sudan black was injected from the earliest proximal tubule with
a collection micropipette (with outer tip diameter of 4 to 8 m)
to fill approximately 3 to 5 diameter-length of the tubule lumen.
Fluid was collected with the minimum degree of suction re-
quired to prevent the oil block from flowing downstream.
Gc and P5 were measured with a continuous recording,
servo-nulling pressure system (model 4A, Instrumentation for
Physiology and Medicine, San Diego, California, USA). For
these measurements, a micropipette with outer tip diameter of
—2 m and containing 2.0 M NaCI was advanced directly into
Bowman's space and the glomerular capillary network. If a
steady pressure tracing was not obtained on the first or second
attempt, the glomerulus was discarded from the study. Hydrau-
lic output from the servo-null system was coupled electronically
to a channel of a direct-writing recorder (Recorder 2400S,
Gould Inc., Cleveland, Ohio, USA) by means of a pressure
transducer. GC and were measured only in nephrons from
which samples for SNGFR were not obtained. All the micro-
puncture measurements were made on rats in a hydropenic
condition [14]. More details of the serial micropuncture meth-
odology and its validation are discussed elsewhere [14].
Histological study
Histological studies were performed using light microscopy
by a pathologist (A.F.) in a blind fashion. The left kidney was
removed and fixed in 10% neutral buffered formalin after
sacrifice and embedded in paraffin'. In the Group I study, to
identify histologically the specific glomeruli which had been
subjected to micropuncture assessment, a small volume of dye
(The Davidson Marking System, Bradley Products, Inc.,
Bloomington, Minnesota, USA) was injected into the subcap-
sular space just above the glomeruli as described in detail
elsewhere [14] immediately prior to sacrifice, In all experimen-
tal groups serial sections (3 m thickness) were made and
stained with periodic acid-Schiff. This approach obviates a bias
of single section examination, namely that there is a greater
chance of larger glomeruli appearing in a single cut of the tissue.
Glomerular sclerosis. A semiquantitative score (sclerosis
index) was used to evaluate the degree of glomerular sclerosis
using the method of Raij, Azar and Keane [17]. A minimum of
ten sections displaying even distribution throughout each gb-
merulus was examined and severity of sclerosis was graded
from 0 to 4+ for each section. Thus, a I + lesion represented
involvement of up to 25% of glomerulus, while 4+ represented
sclerosis of 75 to 100% of glomerulus. A single score was then
obtained for each glomerulus by averaging the scores from
these multiple sections. Using this method the degree of gb-
merular sclerosis was determined in, on average, 6.7 glomeruli
subjected to micropuncture measurements in each remnant
kidney of Group I rats and 20 glomeruli randomly chosen
from surface through the deep cortex in each remnant kidney of
We chose the immersion fixation method rather than perfusion
fixation for our specific experimental purpose. In perfusion fixation it is
the practice to employ a non-pulsatile pressure at a level 5 to 15 mm Hg
above in vivo mean systemic arterial pressure in order to surpass the
systolic pressure. It is felt that such an arbitrary high perfusion
pressure, although it may produce circulating cell-free, expanded
glomerular capillaries, might bias our morphometnc studies by artifac-
tually expanding the glomerulus in non-uniform and unquantitatable
degrees.
Yoshida et a!: Effects of antihypertensives on the glomerulus 629
10 15 20
PA,,,ex, 103mm2
Fig. 2. Relationship between maximum SNGFR and maximum planar
area of glomerulus (PAmax) assessed in the same nephrons (Group I
rats). There was no appreciable correlation between maximum SNGFR
and PAmax (N = 20 from 5 rats, r = 0.023, P> 0.25).
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Group II and III rats. A whole kidney sclerosis index was also
obtained in Groups II and III by averaging the scores for all
glomeruli on a single thin section with a minimum of 50
glomeruli analyzed for comparison of whole kidney sclerosis
between these treatment groups.
Glomerular size. Planar area of glomeruli was determined on
each serial section subjected to the above sclerosis index
scoring using a computerized planimeter (Micro-plan II, Don-
santo Corp., Natick, Massachusetts, USA). Thus, on average,
6.7 micropunctured glomeruli in Group I and a minimum of 20
glomeruli in Groups II and III were examined for PAmax. The
maximum planar area of each glomerulus (PAmax) was used as
an index for the corpuscular size of that specific glomerulus.
The values for PAmax and sclerosis index for each glomerulus
were determined separately and blindly so that the determina-
tion of one would not be biased by the results of the other.
In an additional set of studies, planar area and sclerosis score
were determined for each serial section of 15 glomeruli, weight-
ing the sclerosis score for each section for its planar area. The
sclerosis index was then calculated as above by averaging these
weighted scores. Correlation with the uncorrected sclerosis
index for each of these glomeruli showed a relationship very
close to identity (y = 0.976x + 0.078) with r = 0.997 (P <
.0001). The close similarity between the two scoring methods
can be explained by: 1) the large number of thin sections
examined for each glomerulus, thus minimizing any bias from
any one section; 2) the fact that the spherical shape of the
glomerulus results in comparable planar area of the majority of
thin sections; and 3) that the remaining small population of
near-tangential, extremely small sections were routinely not
included in the analysis to avoid bias. Based on these results,
the unweighted sclerosis index was used for all analyses in the
remaining experiments.
Analytic
BUN was measured using a BUN analyzer (BUN Analyzer
II, Beckman Instruments, Inc., Fullerton, California, USA).
The volume of fluid collected from individual proximal tubules
by micropuncture was estimated from the length of the fluid
column in a constant-bore capillary tube of known internal
diameter.
Statistical analysis
Results are expressed as mean 1 SEM. Comparisons be-
tween two groups were made using the unpaired t-test. Data
from multiple groups were compared using one-way ANOVA
followed by multiple comparisons by the Bonferroni method
[18]. Linear regression analysis was employed to examine the
correlation between the sclerosis index and PAmax. Analysis of
covariance was performed to examine the identity of the
coefficient of slopes [19]. The results were deemed statistically
significant when the P value was <0.05.
Results
Group I (4 to 6 week observation)
Animal and whole kidney data. Body weight measured before
subtotal nephrectomy averaged 228 6 g. At two weeks, body
weight of subtotally nephrectomized rats decreased on average
by approximately 15% (200 9 g). Thereafter, their body
weight increased and the average value at sacrifice was 238 10
g. Systolic arterial pressure increased progressively from 115
4 mm Hg before subtotal nephrectomy up to 174 10 mm Hg
at six weeks. Average value of BUN was 51 mgldl at two weeks
and reached an average value of 59 mg/dl by six weeks.
Relationship between early glomerular hemodynamic pattern
and late glomerular histology. A possible relationship between
the early glomerular hemodynamic patterns as expressed by
micropuncture data and the glomerular size determined histo-
logically in the same glomerulus was examined. Thus, PAmax
was compared to the highest SNGFR (Fig. 2) or P0 values
(Fig. 3). PAmax was also correlated with the sclerosis index
determined in the same glomerulus with no or only modest
sclerosis (SI < 1.5; Fig. 4).
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Fig. 3. Relationship between maximum glomerular capillary hydraulic
pressure (0) and maximum planar area of glomerulus (PAmax)
assessed in the same nephrons (Group I rats). There was no correlation
between maximum P0 and PAmax (N = 25 from 7 rats, r = 0.009, P
> 0.25).
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Fig. 4. Relationship between sclerosis index and maximum planar
area of glomerulus (PAmax) assessed in the same nephrons (Group I
rats). As in Figures 2 and 3, each data point in this and Figures 8 and
9 represents a pair of data for sclerosis index and PAmax determined for
a single glomerulus, by averaging the histological scores given to the
multiple thin sections from the same glomerulus. A significant correla-
tion between sclerosis index and PAmax was detected in glomeruli with
mild to modest sclerosis (sclerosis index < 1.5; N = 45 from 7 rats, r =
0.241, P < 0.005). Glomeruli with advanced sclerosis (sclerosis index 
1.5) had a tendency to have a smaller PAmax (N = 5 from 3 rats, r =
0.618, 0.1 <P < 0.25).
In Figures 2 and 3, values of PAmax are plotted against peak
SNGFR and GC values, respectively, in early stages (0 to 6
weeks). No correlation was found between these variables.
Likewise, although not shown, there was no correlation be-
tween PAmax and the average values of SNGFR and P
obtained in early stages after subtotal nephrectomy. In these
figures, a wide variability among remnant glomeruli is evident
not only in peak SNGFR and PGC but also in PAmax. Since
Bowman's space pressure, P5, uniformly remained essentially
unchanged throughout the study, the time course of glomerular
transcapillary hydraulic pressure difference (P:PGC-PBS) ex-
hibited a pattern identical to that of
In contrast, a significant correlation between glomerular
sclerosis index and PAmax was observed in glomeruli with mild
to modest sclerosis (that is, sclerosis index < 1.5, Y = 0.065X
— 0.572, where Y = sclerosis index and X PAmax in l0
mm2, r = 0.241, P < 0.005; Fig. 4). Glomeruli with advanced
sclerosis (sclerosis index  1.5), although few in numbers, had
a tendency to have progressively smaller PAmax (Y = —0.237X
+ 4.736, r = 0.618, 0.05 <P < 0.10).
Groups II and III (12 week observation)
Animal and whole kidney data. Values for body weight of
Group III rats were significantly higher than those of Group II
rats at 12 weeks; averaging 307 7 g in Group Ill enalapril
treated rats (P < 0.025 vs. Group II) and 296 9 g in Group III
rats treated with triple therapy (P < 0.05 vs. Group II) versus
241 17 g in Group II non-treated control rats, while the
difference between enalapril and triple therapy animals was not
statistically significant.
Values for BUN three days after subtotal nephrectomy (just
before the treatment was started in Group III) were essentially
150
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Fig. 5. The effect o.f anlihypertensive drugs on systemic blood pres-
sure. High systemic blood pressure continued during the experimental
period in non-treated control rats (Group 11). Treatment with enalapril
or triple therapy (Group Ill) effectively prevented systemic hyperten-
sion. * <0.0025, significant difference from that of non-treated control
group assessed by simultaneous multiple comparisons of the Bonferroni
method following one-way ANOVA.
the same between the three experimental groups; 63.5 5.6
mg/dl in Group II non-treated control rats, 60.5 4.3 in Group
III enalapril treated rats and 63.0 4.1 in Group III rats given
triple therapy. Values for BUN markedly increased by 12
weeks in Group II non-treated control rats (148.0 24.1 mg/dl),
whereas BUN remained largely unchanged in Group III, aver-
aging at 12 weeks 69.7 3.4 mg/dl in enalapril rats (P < 0.025
vs. Group II) and 76.8 4.5 in triple therapy rats (P < 0.05 vs.
Group II). The values of the enalapril and triple therapy rats
were not different significantly.
As shown in Figure 5, high systolic blood pressure was
already noted in Group II rats 2 weeks after subtotal nephrec-
tomy (average: 173 to 195 mm Hg), and continued throughout
the subsequent 10 week period. Treatment with enalapril or
triple therapy markedly attenuated systemic hypertension.
Thus, the average value for systolic arterial pressure ranged 111
to 128 mm Hg in the enalapril group and Ill to 124 mm Hg in
the triple therapy group throughout the duration of the study,
and were not significantly different from each other.
Glomerular hemodynamic pattern. Treatment of subtotally
nephrectomized rats with enalapril ameliorated glomerular cap-
illary hypertension: values for P0 averaged 50.2 mm Hg at
three weeks, 50.6 at seven weeks and 49.4 at 12 weeks (Fig. 6),
values markedly lower than those ('—65 mm Hg) measured
previously by us in remnant glomeruli in subtotally nephrecto-
mized rats not given antihypertensive medication [14, 20].
Average values for Ps in Group III enalapril-treated rats were
12.6mm Hg at three weeks, 12.1 at seven weeks and 12.4 at 12
weeks. Thus, average values for transcapillary hydraulic pres-
sure difference, iP (37.6 mm Hg at 3 weeks, 38.5 at 7 weeks and
37.0 at 12 weeks), were, like those for P6, within the range
typically measured in non-nephrectomized rats [14, 21]. In
contrast, with triple therapy, average values for P0c (59.2 mm
Hg at 3 weeks, 57.4 at 7 weeks and 55.8 at 12 weeks) remained
at levels significantly and substantially higher than those with
enalapril (Fig. 6). Since average values for P (12.5 mm Hg at
3 weeks, 13.7 at 7 weeks and 12.7 at 12 weeks) were comparable
with those of enalapril treated rats, average values for P of
triple therapy rats (46.7 mm Hg at 3 weeks, 43.7 at 7 weeks and
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Fig. 6. Time course of glornerular capillary hydraulic pressure (Gc) in
Group III. Treatment with enalapril ameliorated glomerular capillary
hypertension throughout the study. In Contrast, with triple therapy, the
values of remained at levels still substantially higher than those
with enalapril or those typically found in normal glomeruli. *D < 0.025,
significant difference between the two groups by unpaired t-test.
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Fig. 7. Whole kidney glomerular sclerosis index at 12 weeks. Whole
kidney sclerosis index in non-treated control rats (Group 11) was I .88
0.37 (mean 1 SaM). Enalapril and triple therapy largely ameliorated
sclerosis to similar degrees: whole kidney sclerosis index was 0.15
0.04 and 0.22 0.03, respectively. * <0.025, ** <0.0025, significant
difference from that of non-treated control group assessed by simulta- 5 10 15 20 25 30
neous multiple comparisons of the Bonferroni method following one- PAmox, iOmm2
way ANOVA. Triple Tx denotes triple therapy group. Fig. 8. A. Relationship between sclerosis index and PAmax in non-
treated control rats (Group II). There was a significant correlation
between sclerosis index and PAmax in glomeruli without advanced
sclerosis (sclerosis index < 1.5; N = 54 from 6 rats, r = 0.464, P <
0.0001). The slope of the correlation curve was not different signifi-
cantly from that of Group I as determined by analysis of covariance. In
glomeruli with more severe sclerosis (sclerosis index  1.5), there was
a significant inverse correlation between sclerosis index and PAmax(N = 71 from 6 rats, r = 0.134, P < 0.005). B. Relationship between
sclerosis index and PAmax in enalapril treated rats (Group 111). There
was a highly significant correlation between sclerosis index and PAmax
in glomeruli without advanced sclerosis (sclerosis index < 1.5; N = 119
from 6 rats, r = 0.246, P < 0.0001). The slope of the correlation curve
was essentially identical to that of the non-treated control group. C.
Relationship between sclerosis index and PAmax in triple drug-treated
rats (Group Ill). There was a highly significant correlation between
sclerosis index and PAmax in glomeruli without advanced sclerosis
(sclerosis index < 1.5; N = 119 from 6 rats, r = 0.242, P < 0.0001). The
slope of the correlation curve was essentially identical to that of the
non-treated control group.
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43.1 at 12 weeks) were also markedly higher than those of
enalapril treated rats.
Histological study. As shown in Figure 7, whole kidney
sclerosis index in Group II non-treated rats averaged 1.88
0.37, a value significantly higher than those of antihypertensive-
treated groups. Triple therapy and enalapril therapy attenuated
glomerular sclerosis to comparable degrees, indistinguishable
statistically from each other, whole kidney sclerosis index
averaging 0.22 0.03 and 0.15 0.04, respectively.
As for Group I animals (Fig. 4), histological findings obtained
by serial thin section analysis on more than 20 glomeruli from
each of the Group II and III remnant kidneys are presented in
Figure 8 by correlating PAmax with sclerosis index of the same
glomeruli. As in Group I animals, a significant correlation was
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Fig. 9. Relationship between sclerosis index and PAmax from one
kidney in Group II. Sclerosis index correlated positively and highly
significantly with PAmax in glomeruli with mild to modest sclerosis
(sclerosis index < 1.5; N = 11, r = 0.928, P < 0.0001), and inversely
with PAmax in those with advanced sclerosis (sclerosis index  1.5; N
= 10, r = 0.643, P < 0.01).
found between sclerosis index and PAmax in Group II non-
treated rats in glomeruli with mild to modest sclerosis (sclerosis
index < 1.5, Y = 0.082X — 0.928, r = 0.464, P < 0.0001; Fig.
8A). The slope of the correlation curve (correlation coefficient)
was statistically indistinguishable from that of Group I as
determined by analysis of covariance (F = 0.459, P > 0.05). In
the majority of glomeruli with more advanced sclerosis (sclero-
sis index  1.5), PAmax decreased and there was a significant
inverse correlation between sclerosis index and PAmax (Y
—0.064X + 4.402, r = 0.134, P < 0.005). When data are
evaluated for each kidney, these early sclerosis patterns be-
come more evident, and a trend towards smaller glomeruli with
advanced sclerosis persists. Figure 9 shows a correlation be-
tween sclerosis index and PAmax from one kidney of a Group
II non-treated control rat. Sclerosis index correlated positively
and highly significantly with PAmax in glomeruli with mild to
modest sclerosis (Y = 0.117X — 1.631, r = 0.928, P <0.0001),
and inversely, again highly significantly, with PAmax in those
with advanced sclerosis (Y = 0.179X + 6.671, r = 0.643, P <
0.0l).2
As described above, both enalapril and triple therapy (Group
III) prevented development of advanced glomerular sclerosis.
Thus, data points were clustered below the line of sclerosis
index of 1.5 in both Figures SB and SC. Average values of the
2 In accord with a suggestion made by a referee for this article, we
have performed additional examinations of this relationship on an
individual animal basis. We studied 36 to 47 glomeruli per kidney in
three other rats. The slopes of the regression lines for mild sclerosis (SI
< 1.5, x-axis) versus PAmax (y-axis) were very similar with P < 0.005
uniformly, and expressed as: y = 0.146 x —1.731; y = 0.062 x —0.528
and y = 0.074 x —0.844 with reflection points at SI(y) of 1.5. For the
severe sclerosis (SI  1.5) in these three rats, the slopes were y =
—0.057 x +4.397; y = 0.014 x +3.079 and y = —0.075 x +4.326. The
negative regression line had P < 0.05 for one rat. In the remaining two
animals some severely sclerotic glomeruli were found to be large in
association with thrombosis and microangiopathic changes.
sclerosis index from each glomerulus (average values for Y
axis) were 0.47 0.05 (mean I SEM) in enalapril rats and 0.33
0.03 in triple therapy rats, versus 2.08 0.14 in Group II
non-treated rats. Nevertheless, the presence of a significant
correlation between sclerosis index and PAmax was demon-
strated for those with sclerosis index < 1.5 in both enalapnl rats
(Y = 0,060X — 0.723, r = 0.246, P < 0.0001) and triple therapy
rats (Y = 0.057X — 0.618, r 0.242, P < 0.0001). The slopes of
the correlation curve (correlation coefficient) for both groups
were statistically indistinguishable from that of the non-treated
control group (F = 2.087, P > 0.05 and F = 2.991, P > 0.05,
respectively).
strated in the present study. These changes in structure and
function, preceding sclerosis, have been shown in our recent
study [24] to be readily detectable within 4 days after nephrec-
tomy. While the mechanism underlying the hypertrophy of
renal tubules or whole kidney has been extensively studied in a
variety of fashions [25—33], little investigative effort has been
made to identify the specific mechanism(s) involved in the
hypertrophy of remnant glomeruli. In this regard, the marked
internephron heterogeneity which developed within the rem-
nant kidney by four to six weeks after subtotal nephrectomy, in
terms of glomerular filtration rate, capillary hydraulic pressure
and size (Figs. 2 and 3), provided a unique opportunity to
examine the causal role of the two hemodynamic parameters,
that is, SNGFR and for the glomerular hypertrophy. The
degrees of heterogeneity in these parameters were far greater
than those of normal rats reported by us previously [14, 15].
Our examinations among these heterogenous nephrons of the
early hemodynamic pattern and, subsequently, the size of the
same glomerulus, revealed lack of correlation between these
two variables, indicating that the enhanced pressures and flows
prevailing in the remnant glomeruli play little intermediary role
for their hypertrophy. This conclusion echoes the notion estab-
lished at the whole kidney level, that is, the hypertrophy of the
remnant kidney cannot be attributed to its increased work-load
[27, 28, 30—32, 34—36], since an increase in DNA synthesis, as
measured in renal cortical slices, precedes any discernible
increases in whole kidney GFR following nephrectomy [32].
Instead, a circulating "renotropin" has been proposed to me-
diate the renal hypertrophy on the basis of the experimental
observation in a parabiotic system of substantial renal hyper-
trophy in the normal rat when it was connected with an
anephric partner [31, 37—40]. Our findings in the present study
on the remnant glomerulus suggest that the renotropin" acts
as "glomerulotropin" although this may include multiple local
and circulating humoral factors.
At both four to six weeks and 12 weeks after subtotal
nephrectomy, the histology of remnant glomeruli was typically
found to be highly heterogeneous, as both sclerosis index and
PAmax ranged widely (Figs. 4 and 8A). Note that even 12
weeks after subtotal nephrectomy, some glomeruli are free of
glomerular sclerosis (Figs. 8A—C). The presence of many intact
glomeruli indicates lack of correlation between early glomerular
.
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Discussion
—— —
- A number of functional and structural changes occur in5 10 15 20 25 30 remnant nephrons after removal of a large portion of renal
tissue mass [1—4, 9—14, 22, 23]. Among them are an enhanced
hemodynamic pattern and hypertrophy of glomeruli, as demon-
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Table 1. Dosages of antihypertensive drugs used in the three past
and present rat studies
Purkerson
'76
Anderson
'86 Present
Human
dosea
Hydralazine 109 II 27  4.3
Reserpine 0.7 0.7 1.4 0.07
Hydrochlorothiazide 22 3.4 6.8 2.9
Enalapril — 6.8 6.8 0.6
Values are given in mg/kg body weight per day.
a From Physicians' Desk Reference®, 1988. Dosages for rats are
calculated based on 220 g body weight and 30 mI/day consumption of
drinking water in which drugs were dissolved. Those for humans are
based on 70 kg body weight.
functional patterns and the degree of subsequent sclerosis.
Therefore it has been argued that the high glomerular pressures
and flows which appear soon after subtotal nephrectomy cannot
account for the subsequent sclerosis [14]. Not surprisingly,
12-week remnant kidneys had proportionally greater number of
glomeruli with advanced sclerosis than four- to six-week rem-
nant kidneys. In both four- to six-week and l2-week remnant
kidneys, a significant positive correlation was noted between
glomerular size and the degree of sclerosis for glomeruli with
undiscernible-to-mild sclerosis. The relationship between the
two became negative when sclerosis was marked. The latter is
in accord with the familiar finding in human end-stage kidneys
that markedly sclerotic glomeruli are small in size. In our study,
these tendencies of a positive correlation in relatively intact
glomeruli and a negative correlation in glomeruli with advanced
sclerosis are even more prominent within a given kidney (Fig.
9). Mathematically the impact of PAmax in determining sclero-
sis index varies from animal to animal, that is, the somewhat
more scattered points representing the pooled data from all rats
examined (Fig. 8A) may indicate that the susceptibility of
glomeruli to sclerosis at a given PAmax varies more markedly
among individual animals than among glomeruli within a given
animal.
Our studies using antihypertensive drugs showed that both
enalapril and triple-drug medication ameliorated almost com-
pletely the sclerosis in remnant glomeruli. Our observations
with triple drugs are in accord with previous findings by
Purkerson, Hoffsten and Klahr [13], while Anderson, Rennke
and Brenner reported lack of effectiveness of triple drug ther-
apy in protecting remnant glomeruli from sclerosis [3]. It is
likely that the difference among these past and present experi-
mental observations is due to the distinctive difference in the
dosages of antihypertensives used in the studies. Of note,
virtually all of the dosages employed in animal studies exceed
those commonly used in humans (Table I). Nevertheless, our
findings with triple drug therapy and those by Anderson appear
to have important implications with regard to the mechanism
involved in the protective effect of the antihypertensives on the
remnant glomerulus: First, in our study, glomerular sclerosis
was markedly and similarly attenuated by triple therapy and
enalapril although triple therapy exerted only a subtle effect on
the glomerular pressure, in contrast to enalapril, which virtually
normalized glomerular pressure. Second, while our triple drug
therapy was just as ineffective as the lower dose triple drug
therapy used in the study of Anderson et al in regards to
lowering glomerular pressure, glomerular sclerosis was virtu-
ally completely abolished in our study, in contrast to the subtle
minor effect on sclerosis noted in their study [3]. Collectively,
therefore, these findings point to the notion that the antihyper-
tensive drugs exert their antisclerotic actions through mecha-
nism(s) independent of their modulatory role on the glomerular
pressure.
The relationship between sclerosis index and PAmax re-
mained essentially unchanged from four to six weeks to 12
weeks, as indicated by the similar slopes and intercepts on the
X-axis of the regression lines in Figure 4 and Figure 8A. This
finding suggests that the degree of glomerular sclerosis is
mathematically uniquely correlated with the size of the glomer-
ulus independently of the stage after nephrectomy. In other
words, the marked interglomerular heterogeneity in the degree
of sclerosis present in the remnant kidney reflects a variability
in the onset of glomerular hypertrophy which occurs in remnant
nephrons. However, once hypertrophy commences in a given
remnant glomerulus, sclerosis develops in a highly uniform and
predictable manner, where the rate of hypertrophy has a direct
correlation with the rate of progression of sclerosis. In this
regard, our most recent study [24] demonstrated a rapid
achievement of remnant glomerular hypertrophy without dis-
cernible sclerotic changes by day 4 after subtotal nephrectomy,
indicating a presence of a time lag between hypertrophy and the
process of sclerosis within the mesangium. Of note, while
enalapril and triple therapy markedly attenuated both glomeru-
lar hypertrophy and sclerosis, the relationship between PAmax
and sclerosis index found in untreated rats was unaffected by
these antihypertensive therapies as the slopes of the regression
lines expressing their correlation were comparable among un-
treated (Fig. 8A), enalapril-treated (Fig. 8B) and triple drug-
treated rats (Fig. 8C). In our recent study [41] enalapril treat-
ment, similar to the present one, was shown to attenuate the
maturational growth of glomerular size in young rats while it
was without effect on the size of normal adult rat glomeruli.
Overall, it appears that a shared mechanism underlies the
antihypertensive medications' effects to protect remnant gb-
meruli from sclerosis and their suppressive effects on growth of
those glomeruli (Fig. 10). In this regard, our observations made
on individual glomeruli raise an important caveat in interpreting
data from whole kidney examination: Although both modes of
antihypertensive medication appear to have decelerated the
remnant glomeruli to proceed on the up-slopes toward complete
scarring, overall distribution of glomerular size was affected
little due to the biphasic nature of the changes in the size of
remnant glomeruli (Figs. 8A, B, C), implying that these medi-
cations had little effect on average glomerular size determined
at 12 weeks. While Figures 8A, B and C indicate that the
antihypertensive medications were effective on glomeruli which
are on the lower rightward up-slope (that is, hypertrophying
glomeruli), it remains to be determined whether they are also
effective on the gbomeruli on the upper leftward up-slope (that
is, shrinking glomeruli). This issue is currently under extensive
study in our laboratory.
The notion emerges from all of the above observations that
the glomerular hypertrophic process has a tight linkage with
glomerular sclerosis. However, little is known about the biol-
ogy which may interrelate these two phenomena. The recent
observations of the time course of DNA synthesis in the aorta
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Fig. 10. The fate of the remnant glomerulus resulting from severe
nephron loss. Initially, glomerular sclerosis develops in close associa-
tion with hypertrophy. Thereafter, while sclerosis continues to ad-
vance, the glomerular size decreases progressively until the glomerutus
reaches the hyalinized end stage. The onset of hypertrophy and
resulting sclerosis varies among remnant glomeruli within a given
kidney. Once these processes have commenced, however, the sclerosis
progresses in a manner precisely predictable from the degree of
hypertrophic stimulus imposed upon the glomerulus. Although the
antihypertensives (enalapril and triple drug therapy) were effective in
markedly attenuating the progression of glomerular sclerosis, they do
not affect the impact of a given level of hypertrophy on the sclerosis.
Thus, glomeruli with comparable hypertrophy are equally predisposed
to sclerosis, regardless of antihypertensive medication.
of rats with one-clip two-kidney Goldblatt hypertension by
Loeb et al are intriguing [42, 43]. They found enhanced aortic
DNA synthesis five days after the renal arterial clipping, when
no systemic hypertension had yet developed [42]. Administra-
tion of antihypertensive drugs, either captopril, hydralazine or
verapamil prevented this response and development of the
typical Goldblatt hypertension was ameliorated [43]. The anti-
hypertensive drugs used in our study may similarly have had a
direct inhibitory effect on the growth of glomerular cells. If
intracellular calcium mobilization is a common intermediary
step for both glomerular hypertrophy and mesangial matrix
formation, these antihypertensive drugs, known to suppress
cellular calcium uptake, are expected to exert an inhibitory
effect on both hypertrophy and sclerosis in the remnant glomer-
uli.
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